To assess this hypothesis, we evaluated the relationship between IL-6 and circulating MDSC subsets in patients, and the ability of IL-6 to stimulate MDSC accumulation in 4-NQO-induced esophageal tumor model to provide new insights into the development of immune-based therapy. The gene discussed is IL6; the disease is neoplasm of esophagus.